About Penta
Who we are
Diversity and Inclusion
Our Network
Penta Foundation Italy
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Call for services
Brighter Future Award
Archivio
Early versus deferred highly active antiretroviral therapy in HIV infected infants: a European Collaborative Cohort Study.
Increasing Antiretroviral Drug Access for Children With HIV Infection.
Treatment interruption in children with HIV infection.
Does Early Treatment Provide Long Term Benefit in HIV-1 Infected Infants? Five Year Outcomes in Children Treated Before 3 Months of Age in the PENTA 7 Trial.
3TC+ABC maintains virological superiority over ZDV+3TC and ZDV+ABC beyond 5 years in children: the PENTA 5 trial
A comparison of the association of current CD4 cell count with the short-term risk of AIDS and death in HIV-infected children and adults.